Healthcare IT Today

JANUARY 23, 2024

Accenture announced it has made a strategic investment, through Accenture Ventures , in QuantHealth , an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and cost-effectively develop treatments for patients. Petra Jantzer, Ph.D.,

Drug Development 122

Drug Development Pharmaceuticals Life Science BioTech 122

Healthcare IT Today

APRIL 25, 2024

In our interview, Gil emphasizes the critical role of AI in expediting the discovery of new drugs, citing the lengthy and costly nature of traditional drug development processes. However, with AI-driven approaches, Aion Labs is paving the way for a paradigm shift in drug discovery. Tell us what you think.

Pharmaceuticals 137

Pharmaceuticals Drug Development BioTech Life Science 137

Healthcare IT Today

JANUARY 8, 2024

We asked the Healthcare IT Today community to submit their predictions and we received a wide ranging set of responses that we grouped into a number of themes. Discussions will focus on the nuanced packaging and delivery requirements for MABs, emphasizing the commitment to safety standards while ensuring the drugs’ effectiveness.

Health IT 93

Health IT Drug Development Pharmaceuticals BioTech 93

Healthcare IT Today

NOVEMBER 7, 2023

This ML-driven adaptive process can significantly accelerate the clinical drug development process and increase certainty along the way, resulting in more efficient, targeted, and ultimately more successful clinical trials. bringing new needed treatments to patients.”

Drug Development 75

Drug Development BioTech Pharmaceuticals Health IT 75

Healthcare IT Today

MARCH 23, 2023

With the additional funding, Protai will expand its activities to include an oncology drug discovery pipeline, initially focusing on targets with a clearly-defined novel patient population biomarker, derived from its AI proteomics platform. In addition, Protai is supported by leading oncology experts, including Prof.

Drug Development 96

Drug Development BioTech Health IT Healthcare IT 96

Healthcare IT Today

SEPTEMBER 28, 2022

Already, this real-world, distributed time of diagnosis approach, has been used to cut down more than four years of estimated drug development timeline in the instance of PRAX-222, a new therapy for SCN2A, a rare genetic disorder of pediatric epilepsy.

Drug Development 116

Drug Development BioTech Pain management Healthcare IT 116

Healthcare IT Today

JANUARY 9, 2023

We asked the Healthcare IT Today community to submit their predictions and we received a wide ranging set of responses that we grouped into a number of themes. The new year will bear witness to great innovation in biotech in the precision oncology space. The big question that remains is who will have access to these drugs and when?

Health IT 85

Health IT Pharmaceuticals Drug Development Life Science 85